Histopathological Evaluation of Heart Toxicity of a Novel Selective PPAR-γ Agonists CKD-501 in db/db Mice.

Biomol Ther (Seoul) · 2013 · PMC3762307 · PMID 24009864

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A recent outcomes study of pioglitazone showed a trend toward reduction in vascular events but the increased incidence of congestive heart failure (Nesto et al ., 2003) .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.